How to read recurring FDA disputes as diagnostic information — and what each pattern tells you to fix
Most port agents treat FDA disputes as isolated events. A principal pushes back on a charge, the agent resolves it, and both parties move on. When the same principal disputes the same line items on the next port call, the agent resolves it again. And the next time. Each dispute is handled individually, and the pattern is never addressed.
Recurring disputes with the same principal are not a run of bad luck. They are a diagnostic signal pointing to a fixable root cause. The agent who reads them correctly can eliminate the dispute category entirely. The agent who treats each one as a standalone incident will keep having the same conversation indefinitely — while absorbing the cash flow exposure every time.
What Recurring Disputes Are Actually Telling You
When the same line items are disputed by the same principal across multiple port calls, one of three things is happening. Each has a different root cause and requires a different intervention.
Root Cause 1: A systematic documentation gap in the agency's process
The most common cause. The agency has a process step that consistently produces incomplete documentation for a specific charge type. Launch trips are logged inconsistently. CTM receipts are collected at departure instead of at disbursement. Overtime charges go out without the written operational justification the principal expects. The documentation gap is not port-specific or vessel-specific — it is a process gap that shows up on every FDA because the process produces the same incomplete output every time.
The fix here is process-level, not dispute-level. Identify which step is missing, build it into the port call workflow as a non-optional checkpoint, and the dispute category disappears across all principals, not just the one currently pushing back.
Root Cause 2: An authorization threshold mismatch
The agent and the principal have different assumptions about what the agent can approve without prior written authorization. The agent believes that operational necessity is sufficient justification for certain expenditures. The principal's manual of authority says otherwise. This mismatch is particularly common with crew-related expenses, stevedoring extras, and out-of-hours services — categories where the threshold is not always communicated explicitly at appointment.
The fix is a direct conversation about authorization thresholds, held at the start of the relationship and reviewed annually. The question to ask: for each charge category in your typical FDA, what is the maximum the agent can approve without contacting the principal first? Getting that answer in writing, per category, eliminates the authorization ambiguity that drives this dispute pattern.
Root Cause 3: Eroded trust
The least common cause, but the most significant. The principal has stopped giving the agent the benefit of the doubt. Past disputes — resolved or not — have created a disposition to scrutinize rather than approve. In this state, even a clean, well-documented FDA gets queried because the reviewer starts from suspicion rather than from a presumption of accuracy.
The fix here is not better documentation, though better documentation does not hurt. It is a relationship intervention: a direct conversation at the right level of seniority, acknowledging the pattern, identifying what has gone wrong, and agreeing on what a clean FDA process looks like from both sides. Documentation improvements alone will not rebuild trust that has been eroded over multiple disputes.
How to Diagnose Which Root Cause You Are Dealing With
The diagnostic is straightforward. Pull the last three to five disputed FDAs with the principal in question and map the disputed line items across them.
If the same categories appear repeatedly — always launch hire, always miscellaneous, always CTM — and the principal's objection is always documentation-based, the root cause is almost certainly a process gap. The dispute is consistent because the process gap is consistent.
If the disputed categories vary but the common thread is authorization — the principal keeps saying the agent should have asked before committing the expenditure — the root cause is a threshold mismatch. The documentation is often fine; the problem is what the agent approved, not how they documented it.
If the disputes are escalating in tone, if the principal is querying charges that were previously approved without comment, or if the relationship contact at the principal's office has changed recently, the root cause may be eroded trust. The documentation and authorization may both be fine — but the disposition of the reviewer has shifted.
The Conversation That Resolves Repeat Disputes — and the One That Does Not
The conversation that does not resolve repeat disputes is a better explanation of the specific charge. Sending a more detailed breakdown of the launch log, or a longer justification of the overtime, addresses the symptom without touching the root cause. The same dispute will reappear on the next FDA.
The conversation that resolves repeat disputes names the pattern directly. Something like: 'We have noticed that launch hire has been queried on the last four FDAs. We want to understand exactly what documentation you need on this line item, and we want to build that into our standard process so that future FDAs arrive with it already attached.' That conversation is a process alignment conversation, not a dispute resolution conversation.
For authorization threshold mismatches, the conversation is equally direct: 'Can we agree on a written schedule of what we can approve on your behalf without contacting you first, by charge category and by amount? We want to make sure our operating assumptions match your authority thresholds.' That is a one-time conversation that eliminates an entire dispute category.
For eroded trust, the conversation needs to happen at the right level — typically between principals, not between the operational contacts who have been managing the disputes. A trust problem addressed at the operational level is almost never resolved there.
Frequently Asked Questions
How many recurring disputes with the same principal should trigger a process review?
Two occurrences of the same dispute category with the same principal should be enough to trigger a review. A third occurrence confirms the pattern. Waiting for more than three means the agency has absorbed multiple cash flow delays and multiple resolution cycles for a problem that was diagnosable after the second incident. The review does not need to be extensive — map the disputed line items, identify the common thread, and trace it back to the process step that produced the documentation gap.
Should a ship agent absorb a charge that was disputed due to an authorization threshold mismatch?
If the agent committed an expenditure without prior written authorization and cannot demonstrate that authorization existed, absorbing the cost is often the correct outcome — not the most comfortable one, but the honest one. The more productive response is to absorb the current dispute, update the internal authorization process, and initiate the threshold alignment conversation with the principal before the next port call. Absorbing once and fixing the process is significantly less expensive than the same dispute recurring indefinitely.
The Full Picture: All 12 Line Items
Recurring disputes are a pattern problem. Our FDA Disputes Field Guide addresses the individual charge level, the 12 line items most likely to generate pushback, the documentation that resolves each one, and the 18-checkpoint pre-submission checklist that prevents them from arising in the first place. Fixing process at the line item level is the fastest way to break a recurring dispute pattern. Download the guide today.
